Utility of B-natriuretic peptide (BNP) and NT-proBNP (NT) in predicting outcome of hospitalized patients with congestive heart failure

被引：0
|
作者：
Isakson, S [1 ]
Bhalla, V [1 ]
Bhalla, MA [1 ]
Beede, J [1 ]
Clopton, P [1 ]
Gardetto, N [1 ]
Chiu, A [1 ]
Fitzgerald, RL [1 ]
Maisel, A [1 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1731
引用
收藏
页码：U405 / U405
页数：1
相关论文
共 50 条
  • [1] Utility of B-natriuretic peptide (BNP) and NT-proBNP (NT) in predicting outcome of hospitalized patients with congestive heart failure
    Isakson, S
    Bhalla, V
    Bhalla, MA
    Beede, J
    Clopton, P
    Gardetto, N
    Chiu, A
    Fitzgerald, RL
    Maisel, AS
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S197 - S197
  • [2] Utility of NT-proBNP and B-Type Natriuretic Peptide in predicting 90 day mortality of hospitalized patients with congestive heart failure
    Beede, Jennifer
    Isakson, Susan R.
    Gardetto, Nancy J.
    Chiu, Albert
    Clopton, Paul
    Maisel, Alan S.
    CIRCULATION, 2006, 114 (18) : 620 - 621
  • [3] The effect of nesiritide on serum levels of B-natriuretic peptide (BNP) and N-terminal ProBNP (NT-proBNP) in patients admitted for decompensated congestive heart failure
    Fitzgerald, RL
    Cremo, R
    Chiu, A
    Clopton, P
    Bhalla, V
    Maisel, AS
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S52 - S52
  • [4] Utility of B-natriuretic peptide levels in predicting outcome of hospitalized patients with congestive heart failure: Results of the Breathing Not Properly (BNP) Multinational Study
    Maisel, AS
    Bhalla, MA
    Gardetto, N
    McCord, J
    Nowak, RM
    Hollander, JE
    Wu, AHB
    Duc, P
    Omland, T
    Storrow, AB
    Krishnaswamy, P
    Abraham, WT
    Clopton, P
    Steg, G
    Aumont, MC
    Westheim, A
    Knudsen, CW
    Perez, A
    Kamin, R
    Kazanegra, R
    Herrmann, HC
    McCullough, PA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 234A - 234A
  • [5] Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
    Palazzuoli, A.
    Gallotta, M.
    Quatrini, I.
    Nuti, R.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 411 - 418
  • [6] Natriuretic peptide variability in a community heart failure population: is there a difference between BNP and NT-proBNP?
    Hanlon, R. O.
    Lange, S.
    Phelan, D.
    Loughlin, C. O.
    Shea, P. O.
    Ledwidge, M.
    Cunningham, S.
    Mc Donald, K.
    EUROPEAN HEART JOURNAL, 2006, 27 : 214 - 214
  • [7] NT-proBNP in monitoring treatment of patients with congestive heart failure
    Al-Meslmani, Bssam M.
    Fahoum, Sahar K.
    Shamia, Marwan G.
    CLINICAL LABORATORY, 2007, 53 (1-2) : 35 - 39
  • [8] NT-proBNP and BNP: biomarkers for heart failure management
    Bettencourt, P
    EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) : 359 - 363
  • [9] Brain natriuretic peptide (BNP) and N-terminal proBNP (nt-proBNP) in haemodialysis patients
    Racek, J
    Kralova, H
    Eiselt, J
    Trefil, L
    Rajdl, D
    Jerabek, Z
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V297 - V297
  • [10] ARE WE USING BNP WISELY? AUDIT OF THE UTILITY OF NATRIURETIC PEPTIDE TESTING (NT-PROBNP) IN BANES, WILTSHIRE AND SOMERSET FOR PATIENTS WITH SUSPECTED HEART FAILURE
    Kandan, Raveen
    Augustine, Daniel
    Easaw, Jacob
    HEART, 2014, 100 : A24 - A25
12345